Project Grant R01CA295509
Award Date
2/1/25
Completion Date
1/31/30
Dollars Obligated
$435K
Federal Agency
National Cancer Institute
Federal Grant Program
93.353
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This $139,445 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will fund research by the Regents of the University of Michigan to characterize the role of mesothelial-derived cancer-associated fibroblasts (CAFs) in the pathogenesis of pancreatic ductal adenocarcinoma (PDA). The central hypothesis is that mesothelial cells give rise to a distinct, immunomodulatory population of CAFs that influence the PDA tumor microenvironment. Through in...
This federal Project Grant award, valued at $352,141, was provided by the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353). The award will fund research at Wayne State University in Detroit, Michigan to identify ancestry-specific genetic regulators of macrophage function and response to anti-HER2 antibody therapy that may underlie racial disparities in outcomes for HER2-positive breast cancer patients. The research aims to...
This $351,131 federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports research by the University of Miami to mechanistically dissect the signaling interactions between myeloid-derived suppressor cells (MDSCs) and cancer-associated fibroblasts (CAFs) that contribute to chemotherapy and immunotherapy resistance in pancreatic ductal adenocarcinoma (PDAC). The goal is to uncover novel insights into the tumor-permissive and tolerogenic role of...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $728,450.00 to Cold Spring Harbor Laboratory (CSHL) to conduct research on "Communication Between Cancer-Associated Fibroblasts and Neurons Promotes Pancreatic Cancer Progression." The research aims to advance scientific understanding of how interactions between cancer cells and the surrounding non-cancerous cells, such as fibroblasts and neurons,...
The National Cancer Institute (NCI), under the Cancer Research Manpower (CFDA 93.398) federal grant program, awarded a $342,397 Project Grant to Wayne State University to investigate the relationship between MAIT cells and the microbiome in pancreatic cancer liver metastasis. The award period runs from September 30, 2024 to April 28, 2028. The Cancer Research Manpower program supports diverse cancer-related research, training, and career development initiatives across academic and medical...
The National Institutes of Health's National Cancer Institute awarded a $283,136 Project Grant to the Regents of the University of Michigan under the Cancer Research Manpower federal grant program (CFDA 93.398). The award will support research investigating cellular communication in the tumor microenvironment of pancreatic cancer. The grantee will examine how hedgehog signaling alters the immune landscape and endothelial cell function through fibroblast interactions. They will also determine the...
This federal Cooperative Agreement award, funded by the National Cancer Institute under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353), aims to create a comprehensive 3D atlas depicting the progression of pancreatic cancer precursor lesions to invasive pancreatic ductal adenocarcinoma (PDAC) in individuals with genetic defects in DNA repair genes (BRCA1, BRCA2, PALB2). The $1,035,138 award, with a period of performance from Sep 1, 2024 to Aug 31, 2029, will support...
The National Cancer Institute awarded a $193,616 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to a collaborative research partnership between Henry Ford Health and Michigan State University Health Sciences. The grant, which runs from September 1, 2024 to August 31, 2027, will fund research to investigate the molecular mechanisms by which the stress keratin 17 (K17) protein mediates immunosuppression in papillomavirus-induced cancers. The research aims to define the role...
This $163,050 Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower program) supports a research project to investigate the role of Tie2-expressing macrophages (TEMs) in pancreatic ductal adenocarcinoma (PDAC). The key objectives are to: Examine the immunosuppressive functions of circulating and tumor-infiltrating TEMs, particularly their effects on T cell populations in PDAC. Assess the regulatory role of TEMs in PDAC blood vessel function and tumor...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides funding to the University of Texas MD Anderson Cancer Center to conduct research aimed at understanding how mutations in the TP53 tumor suppressor gene drive pro-metastatic interactions between pancreatic cancer cells and the surrounding tumor microenvironment. The $453,304 award will fund a 5-year project focused on clarifying the signaling mechanisms by which mutant TP53 activates the...